Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in the 2025 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association.
Bicara, Zenas outline plans for $180M IPOs amid restored optimism for biotech debuts
Bicara Therapeutics and Zenas BioPharma are now a step closer to kicking open a mini-IPO window for drug developers this fall. The startups outlined plans